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The burden of illness in chronic diseases such as rheumatoid arthritis (RA) can
be expressed in measures of outcome. Ideally, these measures should reflect all
suffering throughout the course of the disease. The impact of RA on the patient's
health and well-being has often been expressed by the 'five Ds' of death,
disability, drug side effects, discomfort, and dollar costs. However, these
outcome rreasures do not fully reflect the burden of illness in the RA patient.
Airn of this thesis was to evaluate some generally used outcome measures as well
as a number of more patient-centered outcome measures giving a better reflec-
tion of the burden of illness in a cohort of patients with recent onset RA at the
start of the study during six years of follow-up. The study was performed at the
University Hospitals of Groningen and Nijmegen and at the Medical Center of
Leeuwarden.
In chapter 2, an assessment of the onset of radiographic damage in the large
joints (hips, knees, shoulders, elbows, ankles and tarsus) and the onset of
atlantoaxial subluxation was performed. Large joint damage appeared to be an
early phenomenon with 20oÁ of the patients having some damage in at least one
large joint within one year, and 50oÁ of the patients within six years after disease
onset. The progression of large joint damage was rrost pronounced in the
patients with the largest progression of damage in their hands and feet, and these
patients had more functional impairment, and had suffered the largest cumulative
disease activity. The disease activity at study entry was the only predictor of
large ioint damage that reached statistical significancy. Atlanto-axial subluxation
did occur early in the disease, particularly in patients with progressive erosive
disease in their hands and feet.
Radiographic progression of damage in hands and feet is considered an
irnportant and objective outcome measure in RA, and is used as a measure of
drug effectiveness. In chapter 3, we evaluated whether the reported largest
increase of radiographic damage in the first years of the disease is a real
phenomenon, or due to a ceiling effect caused by reaching maximum scores for
erosions and/or joint space narowing in individual joints, inherent to the scoring
system. Using the Van der Heijde modification of Sharp's method to assess
radiographic damage, a ceiling effect influenced significantly the mean
radiographic progression after a disease duration of six years. In some individual
patients the ceiling effect appeared to occur earlier. After six years, the maximum
scores were distributed over 50% of the patients, and 20%:o f the patients had
lraxunum scores rn more than ten joints without preference for specific
localisation. Therefore, the ceiling effect appeared to be clinically relevant and
should be taken into account when interpreting the effects of DMARDs on radio-
graphic progression in RA during the first years of the disease. Furthermore, it
rnust be accounted for when describing the relationship between radiographic
progression and process variables, which are used to assess the effect of
DMARDs.
Antirheumatic drugs have to be taken daily by rnost patients with RA, and oÍten
patients have to attend the outpatient clinic and/or laboratory Íbr rnonitoring
purposes. In chapter 4, the burden of illness related to the use of antirheurnatic
drugs was evaluated. lnefficacy appeared to be the main reason tbr DMARD
discontinuation. The rnean nulnber of different DMARDs used was 3.1, and the
rrean number of different NSAIDs 2.4. The rnedian duration of use for the Í'irst
Ílve DMARDs ranged frorr 0.7-2.8 years. The time consurnption due to
anlirheurnatic drug treatment was mainly caused by monitoring for adverse drug
reactions. Thc patients who had the largest radiographic progression and who
suÍïèred the largest curnulative disease activity and physical disability, had the
largest nurnber of DMARD changes.
tlaving a chronic disease such as RA can be very tirne consuming. In chapter 5,
rve tried to quantiÍy the tirne consumption due to treatment and monitoring
activit ies as well as the extra time needed to perform activit ies of daily l iving.
RA patients were compared with a group of asthma and COPD patients. RA as
well as asthrna and COPD appeared indeed to be time consuming diseases. In
particular the activities of daily living and daily disease-related activities were
taking much (extra) time. For the RA patients, there was a reduction of effective
liÍè expectancy, i.e. that part of liÍè that a patient can live according to his own
wishes. ideals or ambition, of at least l l .6%. The time consumption was most
pronounced for the patients with the largest (progression oÍ) radiographic
damage in hands and Íèet, the largest physical disability, and the largest
curnulative disease activity after six years. RF-positivity at study entry was the
only variable that reached statistical significancy as a prognostic factor for time
consurnption. Suggestions were provided for a reduction of the time
consurnption caused by RA.
One possible way to reduce time consumption of patients and doctors is the use
of selÍ'-administered fonns filled in by patients. The self-adrninistration of joint
involvement has already been investigated, however a comparison between
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reproducibilify and the validity to rneasure disease activity of several self-
administered joint counts was evaluated. The joint involvement measured by
patients was reproducible, however, the correlation with the joint examination of
the assessors was moderate. The relation of the self-administered scores and the
assessors' scores with other disease activity variables was comparable. Therefore,
at the present tirne the assessors' joint examination can not be replaced by self-
adrrinistered joint involvement. The value of the selÊadministered joint
involvetnent in the evaluation of disease activitv should be investisated further in
the future.
The literature addressing the socioeconomic consequences of RA for the patient
has rnainly been focussed on work disability. However, the socio-economic
impact should not be restricted to changes in work and income, but also
comprehend Íatigue, recreation, transport mobility, housing facility and social
support. These items were studied in chapter 7, focussing on the impact in the
first years of the disease. Observed socio-economic changes varied frorn nine
percent (removals) to 59oÁ of the cohort (reduced recreation pattern). Concrete
ef-fect rnagnitudes showed work disability to increase by 4-15 times, whereas,
after three years, 42Yo of the patients was registrated 'work disabled'. Due to
fatigue, patients needed extra bedrest (during daytime), recreation changed
towards a lower joint loading pattern and social dependency increased (with
frequencies varying frorn monthly to daily support). Multiple regression analyses
showed socioeconomic changes to be influenced by age, gender, household
composition and work situation. Furthermore, physical lirnitation appeared to be
predictive for work related income reduction, reduced transport rnobility and
development of social dependency.
The prediction of longterm outcome in RA is important for rnany reasons, both
Íbr the individual patient and Íbr the health care providers as well as for health
econornics. In chapter 8 prognostic Íactors for the different outcome measures
and the interrelationship if these outcomes were studied. There was good
relationship between measures of joint damage in small and large joints,
curnulative disease activity (as expressed by rnarkers of the acute phase
response), physical disability, and (for most of them) psycho-social consequen-
ces. The strongest correlations were found between the objective outcome mea-
sures joint darnage and rnarkers of the acute phase response. One third of the
patients could be correctly classified as having a'poor' or a'good' outcome for all
respective outcome measures which shows that the discrimination of outcome
measures in two classes only ('good' or 'poor') has its limitations. C-reactive
1 2 7
protein, an objective indicator of disease activity, appeared to be the best single
predictor of outcome, both when measured at study entry and when measured
serially throughout the course of the disease. The accuracy of the prediction of
physical disability and AIMS (including psycho-social consequences), using the
factors which appeared to be predictive for radiographic damage, was lower than
for the other measures of outcome reflecting the multi-dimensional nature of
disease outcome in RA.
Conclusion: the burden of illness in rheumatoid arthritis is impressive,
particularly for the group of patients with persistent disease activity leading to
progressive joint destruction and functional impairment. Recognition of this
burden is important with respect to e.g. the handling of work (dis)ability
assessments in patients with RA, as well as with respect to the development of
(new) treatment and counselling strategies for these patients and the concomitant
monitoring activities. At all times, we should bear in mind that our patients 'have
rheumatoid arthritis' instead of 'are rheumatoid arthritis'.
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